Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung Adenocarcinoma

ABSTRACT Background Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer. JAM2, a member of the Junctional adhesion molecule (JAM) family, plays diverse roles in cell–cell contacts and tumor development. Although JAM2's expression and functions have been reported in...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun Chen, Yuan Cui, Zhimeng Chen, Hao Ding, Chang Li, Sheng Ju, Cheng Ding, Chun Xu, Jun Zhao, Xin Tong
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.70038
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832577759684067328
author Jun Chen
Yuan Cui
Zhimeng Chen
Hao Ding
Chang Li
Sheng Ju
Cheng Ding
Chun Xu
Jun Zhao
Xin Tong
author_facet Jun Chen
Yuan Cui
Zhimeng Chen
Hao Ding
Chang Li
Sheng Ju
Cheng Ding
Chun Xu
Jun Zhao
Xin Tong
author_sort Jun Chen
collection DOAJ
description ABSTRACT Background Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer. JAM2, a member of the Junctional adhesion molecule (JAM) family, plays diverse roles in cell–cell contacts and tumor development. Although JAM2's expression and functions have been reported in various cancers, its clinical and biological significance in LUAD remains unclear. Aims The aim of this study was to investigate the expression and function of JAM2 in LUAD, and to assess its potential as a prognostic gene and a molecular target for early diagnosis and targeted therapy. Materials Immunohistochemistry (IHC) was performed on 37 pairs of LUAD tissues. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted among co‐expression genes in different JAM2 subgroups. In vitro experiments were also conducted to study the migratory and invasive capabilities of LUAD cells when JAM2 was overexpressed. Results The study confirmed that JAM2 was downregulated in LUAD, possibly due to methylation. JAM2 emerged as an independent prognostic gene for predicting the outcomes of patients with LUAD. IHC analysis revealed the significance of JAM2 with clinicopathological parameters in LUAD. GO and KEGG analyses provided insights into the biological processes and pathways associated with JAM2. In vitro experiments showed that overexpressing JAM2 significantly suppressed the migratory and invasive capabilities of LUAD cells. Additionally, JAM2 played a crucial role in LUAD inflammatory infiltration, and higher JAM2 expression predicted a better immunotherapy response. Conclusion JAM2 may serve as a promising molecular target for early diagnosis and targeted therapy of LUAD. Its downregulation in LUAD, potential role as a prognostic gene, and influence on cell migration, invasion, and inflammatory infiltration make it a valuable target for further research and development of therapeutic strategies.
format Article
id doaj-art-9fd5103e50114bcfa73a7e59a7682528
institution Kabale University
issn 2573-8348
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj-art-9fd5103e50114bcfa73a7e59a76825282025-01-30T15:46:35ZengWileyCancer Reports2573-83482025-01-0181n/an/a10.1002/cnr2.70038Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung AdenocarcinomaJun Chen0Yuan Cui1Zhimeng Chen2Hao Ding3Chang Li4Sheng Ju5Cheng Ding6Chun Xu7Jun Zhao8Xin Tong9Department of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaDepartment of Thoracic Surgery The First Affiliated Hospital of Soochow University Suzhou ChinaABSTRACT Background Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer. JAM2, a member of the Junctional adhesion molecule (JAM) family, plays diverse roles in cell–cell contacts and tumor development. Although JAM2's expression and functions have been reported in various cancers, its clinical and biological significance in LUAD remains unclear. Aims The aim of this study was to investigate the expression and function of JAM2 in LUAD, and to assess its potential as a prognostic gene and a molecular target for early diagnosis and targeted therapy. Materials Immunohistochemistry (IHC) was performed on 37 pairs of LUAD tissues. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were conducted among co‐expression genes in different JAM2 subgroups. In vitro experiments were also conducted to study the migratory and invasive capabilities of LUAD cells when JAM2 was overexpressed. Results The study confirmed that JAM2 was downregulated in LUAD, possibly due to methylation. JAM2 emerged as an independent prognostic gene for predicting the outcomes of patients with LUAD. IHC analysis revealed the significance of JAM2 with clinicopathological parameters in LUAD. GO and KEGG analyses provided insights into the biological processes and pathways associated with JAM2. In vitro experiments showed that overexpressing JAM2 significantly suppressed the migratory and invasive capabilities of LUAD cells. Additionally, JAM2 played a crucial role in LUAD inflammatory infiltration, and higher JAM2 expression predicted a better immunotherapy response. Conclusion JAM2 may serve as a promising molecular target for early diagnosis and targeted therapy of LUAD. Its downregulation in LUAD, potential role as a prognostic gene, and influence on cell migration, invasion, and inflammatory infiltration make it a valuable target for further research and development of therapeutic strategies.https://doi.org/10.1002/cnr2.70038hypermethylationimmune cells infiltrationinvasionJAM2lung adenocarcinomamigration
spellingShingle Jun Chen
Yuan Cui
Zhimeng Chen
Hao Ding
Chang Li
Sheng Ju
Cheng Ding
Chun Xu
Jun Zhao
Xin Tong
Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung Adenocarcinoma
Cancer Reports
hypermethylation
immune cells infiltration
invasion
JAM2
lung adenocarcinoma
migration
title Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung Adenocarcinoma
title_full Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung Adenocarcinoma
title_fullStr Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung Adenocarcinoma
title_full_unstemmed Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung Adenocarcinoma
title_short Aberrant Expression of JAM2 Inhibits Invasion and Migration in Lung Adenocarcinoma
title_sort aberrant expression of jam2 inhibits invasion and migration in lung adenocarcinoma
topic hypermethylation
immune cells infiltration
invasion
JAM2
lung adenocarcinoma
migration
url https://doi.org/10.1002/cnr2.70038
work_keys_str_mv AT junchen aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma
AT yuancui aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma
AT zhimengchen aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma
AT haoding aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma
AT changli aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma
AT shengju aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma
AT chengding aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma
AT chunxu aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma
AT junzhao aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma
AT xintong aberrantexpressionofjam2inhibitsinvasionandmigrationinlungadenocarcinoma